1. Home
  2. MNMD vs TK Comparison

MNMD vs TK Comparison

Compare MNMD & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • TK
  • Stock Information
  • Founded
  • MNMD 2019
  • TK 1973
  • Country
  • MNMD United States
  • TK Bermuda
  • Employees
  • MNMD N/A
  • TK N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • TK Marine Transportation
  • Sector
  • MNMD Health Care
  • TK Consumer Discretionary
  • Exchange
  • MNMD Nasdaq
  • TK Nasdaq
  • Market Cap
  • MNMD 709.9M
  • TK 643.8M
  • IPO Year
  • MNMD N/A
  • TK 1995
  • Fundamental
  • Price
  • MNMD $9.61
  • TK $8.65
  • Analyst Decision
  • MNMD Strong Buy
  • TK
  • Analyst Count
  • MNMD 7
  • TK 0
  • Target Price
  • MNMD $24.71
  • TK N/A
  • AVG Volume (30 Days)
  • MNMD 1.1M
  • TK 526.2K
  • Earning Date
  • MNMD 11-06-2025
  • TK 10-29-2025
  • Dividend Yield
  • MNMD N/A
  • TK 23.04%
  • EPS Growth
  • MNMD N/A
  • TK N/A
  • EPS
  • MNMD N/A
  • TK 0.88
  • Revenue
  • MNMD N/A
  • TK $992,518,000.00
  • Revenue This Year
  • MNMD N/A
  • TK N/A
  • Revenue Next Year
  • MNMD N/A
  • TK N/A
  • P/E Ratio
  • MNMD N/A
  • TK $9.79
  • Revenue Growth
  • MNMD N/A
  • TK N/A
  • 52 Week Low
  • MNMD $4.70
  • TK $5.65
  • 52 Week High
  • MNMD $11.02
  • TK $9.78
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 53.63
  • TK 62.58
  • Support Level
  • MNMD $8.70
  • TK $8.32
  • Resistance Level
  • MNMD $10.04
  • TK $8.91
  • Average True Range (ATR)
  • MNMD 0.50
  • TK 0.20
  • MACD
  • MNMD 0.00
  • TK 0.02
  • Stochastic Oscillator
  • MNMD 73.88
  • TK 66.27

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: